Bayan Health review
The lowest published prices on this masthead, and the plainest way of showing them: an open storefront carrying six figures with no account and no intake in the way. Microdose semaglutide is $99 a month, standard semaglutide $129, microdose tirzepatide $119 and standard tirzepatide $149, each sold once weekly with vitamin B6, with needle-free oral drops of both molecules at the microdose price. The microdose tiers genuinely cost less than the standard ones here, which catches families out elsewhere. Two things deserve weight against all that. The oral drops carry no published evidence for the route, and milligrams by mouth are not interchangeable with milligrams injected. And the same page advertises retatrutide, labeled "GLP-3", as a product coming soon, alongside orforglipron and two oral tablets — retatrutide is investigational and approved for nothing, and "GLP-3" is a nickname rather than a drug class. No state list is published and no dispensing pharmacy is named.
- Independently scored
- Verified
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
Bayan Health at a glance
- Semaglutide
- $129/mo
- Tirzepatide
- $149/mo
- Coverage
- Not published
- Brand-name
- Compounded only
How we scored Bayan Health
Each score comes out of Bayan Health's published pricing, disclosures and oversight, and the six combine into the 52/100 Editors' Rating on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Fair value once you read past any teaser rate or plan structure.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
The headline rate obscures a plan requirement or a hidden step-up.
Little here is shaped around a mother's week or her life stage.
Support is thin once the prescription ships.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
How we verified this review
- Last verified
- September 2026
- Confidence
- medium
- Primary source
- bayantelehealth.com
The cheapest published prices on this masthead, shown the most straightforward way there is: an open storefront with six figures on it and no account required. Microdose semaglutide is $99 a month, standard semaglutide $129, microdose tirzepatide $119 and standard tirzepatide $149, each with vitamin B6. The microdose tiers really are cheaper here, which is not true everywhere. Weigh two things against that. Needle-free oral drops are sold with no published evidence for the route, and the same page advertises retatrutide — marketed as "GLP-3" — as coming soon, a drug approved for nothing. No states are listed and no pharmacy is named.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $129 | Standard, once weekly, with vitamin B6Sold as a monthly subscription. Every price here is on the open storefront before any account, email or intake. |
| Compounded tirzepatide | $149 | Standard, once weekly, with vitamin B6Sold as a monthly subscription. |
| Compounded semaglutide | $99 | Microdose, once weekly, with vitamin B6The lower-dose tier, and genuinely cheaper than the standard one — which is not true of every microdose program we look at. |
| Compounded tirzepatide | $119 | Microdose, once weekly, with vitamin B6The lower-dose tirzepatide tier. |
| Oral semaglutide | $99 | Oral drops, needle-freeA needle-free route at the microdose price. No pharmacokinetic evidence for oral drops is published anywhere on the site. |
| Oral tirzepatide | $119 | Oral drops, needle-freeThe needle-free tirzepatide option, again with no published evidence for the route. |
Swipe the table to see plan details →
GLP-1 telehealth is usually HSA- and FSA-eligible, so check your own plan. Everything above comes from Bayan Health's public disclosures at last review and change often; confirm the current number on Bayan Health's own site.
What we like
- Six prices on an open storefront with no account, email or intake required
- The cheapest published rates on this masthead, from $99 a month
- Microdose tiers genuinely cost less than the standard ones, unlike several sellers
- Both molecules offered needle-free as well as by injection
- Every product states its cadence and that it is billed as a monthly subscription
The caveats
- Advertises retatrutide, marketed as "GLP-3", as coming soon — a drug approved for nothing
- Oral drops are sold with no published pharmacokinetic evidence for the route
- Three further products are listed as coming soon with no price, including two oral tablets
- States served are not enumerated anywhere
- No dispensing pharmacy is named and no accreditation is displayed
- Nothing addresses pregnancy, breastfeeding or postpartum timing
Bayan Health for mothers: our verdict
The lowest published prices on this masthead, and the plainest way of showing them: an open storefront carrying six figures with no account and no intake in the way. Microdose semaglutide is $99 a month, standard semaglutide $129, microdose tirzepatide $119 and standard tirzepatide $149, each sold once weekly with vitamin B6, with needle-free oral drops of both molecules at the microdose price. The microdose tiers genuinely cost less than the standard ones here, which catches families out elsewhere. Two things deserve weight against all that. The oral drops carry no published evidence for the route, and milligrams by mouth are not interchangeable with milligrams injected. And the same page advertises retatrutide, labeled "GLP-3", as a product coming soon, alongside orforglipron and two oral tablets — retatrutide is investigational and approved for nothing, and "GLP-3" is a nickname rather than a drug class. No state list is published and no dispensing pharmacy is named. It runs about $129/month, flat across every dose — toward the affordable end of what we track.
We weigh Bayan Health the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the things a generic roundup never gets to.
What Bayan Health actually costs
- Compounded semaglutide — Standard, once weekly, with vitamin B6: $129/mo
- Compounded tirzepatide — Standard, once weekly, with vitamin B6: $149/mo
- Compounded semaglutide — Microdose, once weekly, with vitamin B6: $99/mo
- Compounded tirzepatide — Microdose, once weekly, with vitamin B6: $119/mo
- Oral semaglutide — Oral drops, needle-free: $99/mo
- Oral tirzepatide — Oral drops, needle-free: $119/mo
That sits below the roughly $179 median ongoing price across the providers we track for mothers — a real cost advantage.
The medications Bayan Health prescribes
Bayan Health prescribes semaglutide and tirzepatide — the pair with the strongest evidence behind them, and having both under one account matters when insulin resistance, familiar from PCOS and gestational diabetes, makes tirzepatide the better fit. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
A needle-free oral or sublingual option is on the menu, which draws in mothers who've been avoiding injections — just set expectations: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used.
Where Bayan Health fits — and where it doesn't — for mothers
Worth it if…
- the real monthly cost is a real barrier and you want a low, predictable number.
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Give it a miss if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
Bayan Health is a genuine value play — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: A family shopping mainly on price who wants every figure visible before handing anything over, and who will stay on the two established molecules.
Alternatives to Bayan Health
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing Bayan Health
Head-to-head & alternatives
Bayan Health, answered
- Why does retatrutide matter if it is only "coming soon"?
- Because it is not an approved medicine. Retatrutide is still investigational, approved for nothing, and advertising it as a forthcoming product invites a family to plan around a research compound. The "GLP-3" label is marketing rather than pharmacology — the three counts receptors on a triple agonist, and two of those are not GLP receptors. Three other products on the same page are listed as coming soon with no price.
- Are the oral drops the same as the injection?
- Nothing published shows that they are. Bayan sells needle-free drops of both molecules at $99 and $119 a month with no pharmacokinetic data for the route. Milligrams taken by mouth are not interchangeable with milligrams injected, so a dose that sounds comparable may not be. If avoiding needles matters to you, ask what evidence supports the dose you would be given.
- Is the microdose genuinely cheaper?
- Yes, and that is worth saying because it often is not. Microdose semaglutide is $99 against $129 for standard, and microdose tirzepatide $119 against $149. Several sellers we look at price their microdose above their standard program, which catches out families who chose microdosing to spend less.
Pricing, states and verification reflect Bayan Health's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.